Calithera Biosciences (CALA) Short Interest Ratio & Short Volume $0.0002 0.00 (0.00%) As of 11:47 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Calithera Biosciences Short Interest DataCalithera Biosciences (CALA) has a short interest of 6,800 shares, representing 0.15% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 13.6, indicating that it would take 13.6 days of the average trading volume of 9,680 shares to cover all short positions.Current Short Interest6,800 sharesPrevious Short Interest6,800 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.00Short Interest Ratio13.6 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares4,870,000 sharesShort Percent of Float0.15%Today's Trading Volume474 sharesAverage Trading Volume9,680 sharesToday's Volume Vs. Average5% Short Selling Calithera Biosciences? Sign up to receive the latest short interest report for Calithera Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCALA Short Interest Over TimeCALA Days to Cover Over TimeCALA Percentage of Float Shorted Over Time Calithera Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20256,800 shares $0.00 No Change0.1%13.6 $0.00 7/15/20256,800 shares $0.68 -65.0%N/A2.5 $0.00 6/30/202519,400 shares $19.40 No Change0.4%8.4 $0.00 6/15/202519,400 shares $38.80 No Change0.4%48.5 $0.00 5/31/202519,400 shares $54.32 No Change0.4%97 $0.00 5/15/202519,400 shares $11.64 No ChangeN/A6.1 $0.00 4/30/202519,400 shares $97.00 No ChangeN/A194 $0.01 4/15/202519,400 shares $11.64 No ChangeN/A6.7 $0.00 3/14/202519,400 shares $11.64 No ChangeN/A0.3 $0.00 2/28/202519,400 shares $11.64 No ChangeN/A194 $0.00 Get the Latest News and Ratings for CALA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/14/202519,400 shares $11.64 No ChangeN/A97 $0.00 1/31/202519,400 shares $11.64 No ChangeN/A0.8 $0.00 1/15/202519,400 shares $1.94 No ChangeN/A4.5 $0.00 1/31/2023366,600 shares $150.31 thousand -12.2%7.7%1.2 $0.41 1/15/2023417,300 shares $219.62 thousand +35.0%8.7%1.9 $0.53 12/30/2022309,200 shares $1.01 million +108.2%6.5%1.7 $3.26 12/15/2022148,500 shares $246.51 thousand +0.6%3.1%2 $1.66 11/30/2022147,600 shares $287.82 thousand +0.3%3.1%2.5 $1.95 11/15/2022147,200 shares $350.34 thousand -14.4%3.1%2.2 $2.38 10/31/2022171,900 shares $431.47 thousand -7.9%3.6%2.3 $2.51 10/15/2022186,600 shares $464.63 thousand +18.9%4.0%2.1 $2.49 9/30/2022156,900 shares $461.29 thousand +20.3%3.4%1.5 $2.94 9/15/2022130,400 shares $481.18 thousand +6.1%2.8%1.6 $3.69 8/31/2022122,900 shares $478.08 thousand -32.3%2.6%1.1 $3.89 8/15/2022181,600 shares $750.92 thousand +6.4%3.9%1.4 $4.14 7/31/2022170,700 shares $542.83 thousand +18.4%3.7%1.1 $3.18 7/15/2022144,200 shares $376.36 thousand -27.2%3.2%0.8 $2.61 6/30/2022198,100 shares $487.33 thousand +70.5%4.4%1.1 $2.46 6/15/2022116,200 shares $6.39 million -93.7%3.1%0.6 $55.00 5/31/20221,850,000 shares $379.99 thousand -10.2%N/A0.5 $0.21 5/15/20222,060,000 shares $473.80 thousand +28.8%N/A0.7 $0.23 4/30/20221,600,000 shares $393.60 thousand -37.0%N/A0.7 $0.25 4/15/20222,540,000 shares $787.40 thousand +32.3%N/A0.9 $0.31 3/31/20221,920,000 shares $775.68 thousand +22.3%2.7%0.9 $0.40 3/15/20221,570,000 shares $712.78 thousand +20.8%2.3%1.1 $0.45 2/28/20221,300,000 shares $630.50 thousand -2.3%1.9%0.9 $0.49 2/15/20221,330,000 shares $658.48 thousand +23.2%1.9%0.8 $0.50 1/31/20221,080,000 shares $702 thousand +133.7%1.6%0.5 $0.65 1/15/2022462,100 shares $250.46 thousand +18.2%0.7%0.2 $0.54 12/31/2021391,100 shares $260.08 thousand -36.3%0.6%0.2 $0.67Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad)Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.We recently interviewed Rickards to get the full story and understand how everyday Americans can pre 12/15/2021613,700 shares $435.17 thousand -3.0%0.9%0.4 $0.71 11/30/2021632,500 shares $523.46 thousand -29.8%0.9%0.4 $0.83 11/15/2021900,900 shares $909.91 thousand -58.9%1.3%0.6 $1.01 10/29/20212,190,000 shares $4.23 million +10.6%3.2%1.9 $1.93 10/15/20211,980,000 shares $4.04 million +12.5%2.9%3.7 $2.04 9/30/20211,760,000 shares $3.84 million +7.3%2.6%3.1 $2.18 9/15/20211,640,000 shares $3.44 million -31.7%2.4%2.3 $2.10 8/31/20212,400,000 shares $5.88 million -9.8%3.5%3.3 $2.45 8/13/20212,660,000 shares $6.09 million +35.0%3.9%3.2 $2.29 7/30/20211,970,000 shares $3.84 million -6.6%2.9%2 $1.95 7/15/20212,110,000 shares $4.28 million -3.7%3.1%2.1 $2.03 6/30/20212,190,000 shares $4.58 million -28.4%3.2%2.2 $2.09 6/15/20213,060,000 shares $6.85 million +1.0%4.5%3.5 $2.24 5/28/20213,030,000 shares $6.91 million -5.6%4.5%3.3 $2.28 5/14/20213,210,000 shares $6.36 million +23.9%N/A3.4 $1.98 4/30/20212,590,000 shares $5.70 million +15.1%N/A2.8 $2.20 4/15/20212,250,000 shares $4.93 million +24.3%N/A2.1 $2.19 3/31/20211,810,000 shares $4.42 million -0.6%N/A1.3 $2.44 3/15/20211,820,000 shares $5.26 million -28.1%N/A1.1 $2.89 2/26/20212,530,000 shares $7.36 million -15.7%N/A1.5 $2.91 2/12/20213,000,000 shares $9.33 million -9.1%N/A1.8 $3.11 1/29/20213,300,000 shares $9.60 million -7.6%N/A2.2 $2.91 1/15/20213,570,000 shares $13.07 million +10.9%N/A2.5 $3.66 12/31/20203,220,000 shares $16.45 million +59.4%N/A2.9 $5.11 12/15/20202,020,000 shares $9.92 million +5.8%N/A3.2 $4.91 11/30/20201,910,000 shares $9.34 million -30.0%N/A3.6 $4.89 11/15/20202,730,000 shares $12.56 million -11.1%N/A5.1 $4.60 10/30/20203,070,000 shares $11.02 million -5.3%N/A6.3 $3.59 10/15/20203,240,000 shares $12.73 million +0.3%N/A5.8 $3.93 9/30/20203,230,000 shares $11.14 million -0.3%N/A5.7 $3.45 9/15/20203,240,000 shares $11.63 million -0.6%N/A5.3 $3.59 8/31/20203,260,000 shares $13.14 million +4.8%N/A5.4 $4.03 CALA Short Interest - Frequently Asked Questions What is Calithera Biosciences' current short interest? Short interest is the volume of Calithera Biosciences shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 6,800 shares of CALA short. 0.15% of Calithera Biosciences' shares are currently sold short. Learn More on Calithera Biosciences' current short interest. What is a good short interest ratio for Calithera Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CALA shares currently have a short interest ratio of 14.0. Learn More on Calithera Biosciences's short interest ratio. What is a good short interest percentage for Calithera Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.15% of Calithera Biosciences' floating shares are currently sold short. How does Calithera Biosciences' short interest compare to its competitors? 0.15% of Calithera Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Calithera Biosciences: Ampio Pharmaceuticals, Inc. (0.01%), PaxMedica, Inc. (0.01%), Clever Leaves Holdings Inc. (0.52%), eFFECTOR Therapeutics, Inc. (0.13%), OncoSec Medical Incorporated (0.00%), Eloxx Pharmaceuticals, Inc. (0.08%), Indivior PLC (6.48%), InterCure Ltd. (0.09%), Minerva Neurosciences, Inc (0.56%), NexImmune, Inc. (0.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Calithera Biosciences stock? Short selling CALA is an investing strategy that aims to generate trading profit from Calithera Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Calithera Biosciences? A short squeeze for Calithera Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CALA, which in turn drives the price of the stock up even further. How often is Calithera Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CALA, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies AMPE Short Interest PXMD Short Interest CLVR Short Interest EFTR Short Interest ONCSQ Short Interest ALVOW Short Interest BCTXW Short Interest CLVRW Short Interest CMRAW Short Interest EFTRW Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CALA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calithera Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Calithera Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access